Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis-Reference-Cited by-同舟云学术

Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis

Published:2017-08 Issue:8 Volume:101 Page:1859-1866
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Mouchli Mohamad A.,Singh Siddharth,Loftus Edward V.,Boardman Lisa,Talwalkar Jayant,Rosen Charles B.,Heimbach Julie K.,Wiesner Russell H.,Hasan Bashar,Poterucha John J.,Kymberly Watt D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference47 articles.

1. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit;Collett;Am J Transplant,2010

2. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data;Jain;Transplantation,1998

3. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection;Schrem;Liver Transpl,2013

4. Risk of malignant neoplasms after liver transplantation: a population-based study;Aberg;Liver Transpl,2008

5. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study;Jiang;Liver Transpl,2008

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary sclerosing cholangitis and other risk factors for post-transplant lymphoproliferative disease after liver transplantation in adults;Liver Transplantation;2023-09-13

2. Main factors influencing long-term outcomes of liver transplantation in 2022;World Journal of Hepatology;2023-03-27

3. Comprehensive Complication Index to Monitor Morbidity and Mortality After Liver Transplantation in Primary Sclerosing Cholangitis;Annals of Surgery;2023-02-24

4. “De novo” cholangiocarcinoma 20 years after liver transplantation for primary sclerosing cholangitis: Lifelong screening needed!;Clinics and Research in Hepatology and Gastroenterology;2022-04

5. De Novo Intrahepatic Cholangiocarcinoma After Deceased Donor Liver Transplant in an Adult Patient;Experimental and Clinical Transplantation;2022-03